Invention Grant
- Patent Title: Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies
-
Application No.: US17231782Application Date: 2021-04-15
-
Publication No.: US11428694B2Publication Date: 2022-08-30
- Inventor: Robert Ziemann , April Ahlberg , David Hawksworth , Bryan Tieman , A. Scott Muerhoff , Christopher Marohnic , Kathy Otis
- Applicant: Abbott Laboratories
- Applicant Address: US IL Abbott Park
- Assignee: Abbott Laboratories
- Current Assignee: Abbott Laboratories
- Current Assignee Address: US IL Abbott Park
- Agency: Casimir Jones SC
- Agent Lisa Mueller
- Main IPC: G01N33/576
- IPC: G01N33/576 ; C07K16/00 ; C07K16/10
Abstract:
The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.
Public/Granted literature
- US20210231665A1 DETECTION METHODS EMPLOYING HCV CORE LIPID AND DNA BINDING DOMAIN MONOCLONAL ANTIBODIES Public/Granted day:2021-07-29
Information query
IPC分类:
